Cross GB, Sari IP, Kityo C, Lu Q, et al. Rosuvastatin adjunctive therapy for rifampicin-susceptible pulmonary tuberculosis: a phase 2b, randomised, open-label, multicentre trial. Lancet Infect Dis 2023 Mar 23:S1473-3099(23)00067.
PMID: 36966799